At a glance
ClinicalIndex Comparison RecordN/ACompleted· 219 enrolled
Drug / intervention
Theravent +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Controlled Trial for Assessment of a Novel Non-Pharmacologic Intervention for Decrease in Altitude Illness
In Brief
A clinical study evaluating Theravent and Control for Acute Mountain Sickness. Completed, enrolled 219 participants across 1 site.
Detailed Summary
The study is examining if an over-the-counter device (Theravent) worn while sleeping can reduce acute mountain sickness upon awakening in a high altitude trekking population.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Mountain Sickness
CountriesNepal
CollaboratorsUniversity of Utah
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 2013
Enrollment StartOct 2013
Primary CompletionDec 2013
Study CompletionOct 2014
TodayJul 2026
First PostedApr 30, 2013
Enrollment StartOct 1, 2013
Primary CompletionDec 1, 2013
Study CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 13.2 years ago
Interventions
Theraventdevice
nasal EPAP device
Controldevice
Sham device without EPAP